Contributor

Loose Women presenter Nadine Sawalha joined patients, campaigners and charities to strip off and go topless to reveal their painted chests outside Parliament in a desperate bid 'to be seen’ and heard by the new government over a 'game-changing' breast cancer drug called ‘Enhertu’ on the 10th of July 2024 in Westminster, London, United Kingdom. It was a group of 31 women touched by breast cancer - 31 to represent the lives that are lost to metastatic breast cancer each day in the UK. The 'game-changing' drug called ‘Enhertu’ is available in Scotland and 14 other countries, but not currently in England and Wales. Enhertu is a targeted (biological) therapy which interferes with processes in cells that help cancer grow. It is used on patients with metastatic HER2 breast cancer and has been clinically proven to extend the patients life. (Photo by Andy Aitchison)

Add to Lightbox Download

Filename: 2024-Protest-Breast-Cancer-1153.jpg
Copyright: Andrew Aitchison
Image Size: 4724x3151 / 3.5MB; www.andrewaitchison.com; 31 women Aitchison Big Ben England Enhertu HER2-LOW London Loose Women Parliament Parliament Square UK United Kingdom Westminster be seen bear cancer boobs bossom breast cancer breast cancer drug campaigners charities desperate bid game-changing game-changing drug government mastectomy metastatic breast cancer painted chest patients presenter protest r Nadine Sawalha strip off topless
Contained in galleries: Going Topless To Be Heard About Breast Cancer

Loose Women presenter Nadine Sawalha joined patients, campaigners and charities to strip off and go topless to reveal their painted chests outside Parliament in a desperate bid 'to be seen’ and heard by the new government over a 'game-changing' breast cancer drug called ‘Enhertu’ on the 10th of July 2024 in Westminster, London, United Kingdom. It was a group of 31 women touched by breast cancer - 31 to represent the lives that are lost to metastatic breast cancer each day in the UK. The 'game-changing' drug called ‘Enhertu’ is available in Scotland and 14 other countries, but not currently in England and Wales. Enhertu is a targeted (biological) therapy which interferes with processes in cells that help cancer grow. It is used on patients with metastatic HER2 breast cancer and has been clinically proven to extend the patients life. (Photo by Andy Aitchison)